CN104491403A - Medicine for treating central retinochoroiditis and preparation method - Google Patents
Medicine for treating central retinochoroiditis and preparation method Download PDFInfo
- Publication number
- CN104491403A CN104491403A CN201410739266.8A CN201410739266A CN104491403A CN 104491403 A CN104491403 A CN 104491403A CN 201410739266 A CN201410739266 A CN 201410739266A CN 104491403 A CN104491403 A CN 104491403A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- rhizoma polygonati
- fructus
- retinochoroiditis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 84
- 201000004709 chorioretinitis Diseases 0.000 title claims abstract description 20
- 229940079593 drug Drugs 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004744 fabric Substances 0.000 claims abstract description 7
- 230000001225 therapeutic effect Effects 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 6
- 238000002386 leaching Methods 0.000 claims description 6
- 230000003204 osmotic effect Effects 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 2
- 241000830535 Ligustrum lucidum Species 0.000 abstract 2
- 244000241838 Lycium barbarum Species 0.000 abstract 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 240000000249 Morus alba Species 0.000 abstract 2
- 235000008708 Morus alba Nutrition 0.000 abstract 2
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 238000007789 sealing Methods 0.000 abstract 2
- 238000002791 soaking Methods 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 230000004438 eyesight Effects 0.000 description 19
- 206010030113 Oedema Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010063341 Metamorphopsia Diseases 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000029257 vision disease Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 206010025421 Macule Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010003084 Areflexia Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010013789 Dry throat Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000009978 visual deterioration Effects 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical group CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 2
- 206010025415 Macular oedema Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 206010043189 Telangiectasia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000010230 macular retinal edema Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 208000009056 telangiectasis Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004127 vitreous body Anatomy 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating central retinochoroiditis and a preparation method. The medicine comprises the following various components in parts by mass: 1-3 parts of rehmannia glutinosa, 1-3 parts of mulberry, 1-3 parts of wolfberries, 1-3 parts of sealwort, 1-3 parts of radix polygonati officinalis, 1-3 parts of cortex moutan, 1-3 parts of glossy privet fruit, 1-3 parts of salvia miltiorrhiza, 1-3 parts of safflower carthamus and 1-3 parts of caulis spatholobi. The preparation method of the medicine comprises the following steps: selecting high-quality and clean first-grade rehmannia glutinosa, mulberry, wolfberries, sealwort, radix polygonati officinalis, cortex moutan, glossy privet fruit, salvia miltiorrhiza, safflower carthamus and caulis spatholobi in parts by mass, and crushing the components into grains for later use respectively; filling the crushed granular medicines in a cloth bag and sealing, soaking in clean water for about half hour until medicine tissues are permeated, then placing the soaked medicines and the clarified liquid for soaking the medicine in a decocting machine, injecting cold boiled water one inch higher than the medicines and decocting for 25 minutes for the first time, filtering to take the medicine liquid, then injecting slight warm boiled water and decocting for 20 minutes for the second time, combining the decoctions and concentrating into 1080ml of 50% traditional Chinese medicine liquid, and bagging and sealing.
Description
Technical field
The present invention relates to field of Chinese herbal medicine technology, be specifically related to a kind of medicine of therapeutic community's property retinochoroiditis, particularly for the medicine of anthropocentric property retinochoroiditis patient and the field of preparation method.
Background technology
Central retinochoroiditis is a kind of more common retinopathy, and affected area is mainly limited to macular area.Clinical main manifestations is: blurred vision, seemingly has yarn curtain to hide at the moment, and has vision obscure and metamorphopsia, and their early stage is often with homonymy migraine.First there is macular edema in examination of ocular fundus.Visible circular, the oval or random scatters halation at edema edge, central pit areflexia.Macular area retina swells in vitreous body.Edema area is common has yellow-white or canescence circle to ooze out point, and transudate can be transparent or become muddiness because there is fibrin in liquid.The retinal manifestations of some cases is that simple edema thickens, and the small artery be commonly considered as near macular area shrinks, and makes the telangiectasis of surrounding, causes serosity to infiltrate in neighbouring tissue, thus forms the stagnant phenomenon of surrounding tissue.Any vestige can not be left after this kind of case recovery from illness, vision is unaffected, or seldom be affected.But majority of cases oozes out to show as master clinically.This kind of case, after edema extinction, along with the progressively absorption of exudate, often leaves over tiny pigment, and after recovery from illness, central vision can have impact in various degree.
So, just how finding a kind of medicine effectively can treating above-mentioned central retinochoroiditis, is our current problem in urgent need to solve.
Summary of the invention
The object of this invention is to provide a kind of medicine and preparation method of therapeutic community's property retinochoroiditis, to solve central serous chorioretinopathy patient restorative problem early.This medicine is that have advantages of perfect compatibility, hit pathogenesis with common Chinese herbal medicine for raw material, has fully demonstrated the Therapeutic Principle of nourishing the liver and kidney and blood circulation promoting and blood stasis dispelling.
For reaching the object of foregoing invention, the technical solution adopted in the present invention is: the medicine and the preparation method that provide a kind of therapeutic community's property retinochoroiditis, is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Rehmanniae Preparata 1-3 part;
Fructus Mori 1-3 part;
Fructus Lycii 1-3 part;
Rhizoma Polygonati 1-3 part;
Rhizoma Polygonati Odorati 1-3 part;
Cortex Moutan 1-3 part;
Fructus Ligustri Lucidi 1-3 part;
Radix Salviae Miltiorrhizae 1-3 part;
Flos Carthami 1-3 part;
Caulis Spatholobi 1-3 part.
According to the medicine of therapeutic community's property retinochoroiditis provided by the present invention, it is characterized in that, each component of described medicine and mass parts thereof are than as follows:
1 part, Radix Rehmanniae Preparata;
1 part, Fructus Mori;
Fructus Lycii 1 part;
Rhizoma Polygonati 1 part;
Rhizoma Polygonati Odorati 1-part;
Cortex Moutan 1 part;
Fructus Ligustri Lucidi 1 part;
Radix Salviae Miltiorrhizae 1 part;
1 part, Flos Carthami;
Caulis Spatholobi 1 part.
The medicine of therapeutic community's property retinochoroiditis and a preparation method, is characterized in that, described method comprises the steps:
A, 1 part, the one-level Radix Rehmanniae Preparata selecting high-quality clean, 1 part, Fructus Mori, Fructus Lycii 1 part, Rhizoma Polygonati 1 part, Rhizoma Polygonati Odorati 1 part, Cortex Moutan 1 part, Fructus Ligustri Lucidi 1 part, Radix Salviae Miltiorrhizae 1 part, 1 part, Flos Carthami, Caulis Spatholobi 1 part, be ground into graininess for subsequent use respectively;
B, the above-mentioned granular medicament that crushes to be loaded in cloth bag after tying, soak in water purification about half an hour, with osmotic drug degree of being organized as, then the clear liquor of soaked medicine and soak medicine is put into boiling machine in the lump, the cold boiled water injecting medicine one-inch carries out first time decoction 25 minutes, after leaching medicinal liquid, re-injects tepor boiled water and carries out second time decoction 20 minutes, merge the herb liquid 1080 milliliters being condensed into 50%, packedly to seal.
The medicine of therapeutic community's property retinochoroiditis and a preparation method, is characterized in that, described instructions of taking is: will decoct well-done herb liquid and divide and take for two days, the morning, noon and afternoon service once, dosage 180 milliliters/time, taking medicine before meal.To take medicine 34-38 agent, transference cure.
Herb liquid provided by the present invention is oral traditional Chinese medicine composition, and it for raw material, gives full play to the property of medicine of each component with common Chinese herbal medicine:
Radix Rehmanniae Preparata, nature and flavor, sweet in the mouth, warm in nature, there is effect that moist, beneficial essence of enriching blood fills out marrow, be used for the treatment of dizzy cardiopalmus, menoxenia, collapse that more than, hepatic and renal YIN deficiency, hectic fever night sweat, seminal emission sexual impotence, infertility, soreness of the waist and knees, Hiccough and deaf, the head are dim-sighted, early whitening of beard and hair, quench one's thirst, constipation, the diseases such as dyspnea with rapid and short breath of suffering from a deficiency of the kidney;
Fructus Mori, nature and flavor: sweet, cold tonifying liver, there is kidney tonifying, relieve dizziness, high fever, infantile convulsions, epilepsy, etc., grow effect of liquid, be used for the treatment of hepatic and renal YIN deficiency, quench one's thirst, constipation, order secretly, tinnitus, scrofula, articular instability;
Fructus Lycii, nature and flavor: sweet, flat, have effect of nourishing the liver and kidney, replenishing vital essence to improve eyesight, be used for the treatment of asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, impotence and seminal emission, interior-heat are quenched one's thirst, blood deficiency and yellow complexion, blurred vision are not clear;
Rhizoma Polygonati, nature and flavor: sweet in the mouth, property are flat, there is effect of spleen reinforcing, lung moistening, promoting the production of body fluid to quench thirst, spleen invigorating, be used for the treatment of anorexia and loose stool, fatigue and lack of strength and Liver and kidney blood and essence asthenia that weakness of the spleen and stomach causes, all diseases that deficiency and damage of lung-QI causes, cardiovascular and cerebrovascular vessel can also be protected, reduce blood fat, reduce the disease such as blood glucose, enhancing human body immunity function;
Rhizoma Polygonati Odorati, nature and flavor: sweet, flat, have effect of nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid, be used for the treatment of cough caused by dryness, chronic cough, the dry throat and mouth of calentura cloudy liquid consumption wound, interior-heat are quenched one's thirst, deficiency of YIN diseases caused by exogenous pathogenic factor, dizzy, the muscle arteries and veins spasm and pain of giddy;
Cortex Moutan, nature and flavor: cold nature, bitter in the mouth are pungent, have purify the blood, invigorate blood circulation, effect of dissipating blood stasis, be used for the treatment of macule haematemesis, amenorrhea due to stagnation of blood, premenstrual gesture, carbuncle sore tumefacting virus, traumatic blood stasis, the deficiency of YIN send out gesture, lossless hectic fever due to YIN-deficiency;
Fructus Ligustri Lucidi, nature and flavor: sweet, bitter, flat, have effect of liver and kidney tonifying, clearind deficient heat, strong waist knee joint, improve visual and auditory acuity, black beard and hair, are used for the treatment of Light-headedness, soreness of the waist and knees, seminal emission, tinnitus, early whitening of beard and hair, poor vision;
Radix Salviae Miltiorrhizae, nature and flavor: bitter, be slightly cold, there is effect of promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind, be used for the treatment of menoxenia, the disease such as amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swell and ache, dysphoria and insomnia, hepatosplenomegaly, angina pectoris;
Flos Carthami, nature and flavor: acrid in the mouth, warm in nature, have effect of promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing, are used for the treatment of dysmenorrhea, amenorrhea, puerperal blood faints, the stagnant stomachache of the stasis of blood, obstruction of qi in the chest and cardialgia, accumulation of blood, traumatic injury congestive edema, arthralgia, paralysis due to windstroke, macular eruption being dark-purple;
Caulis Spatholobi, nature and flavor: bitter in the mouth, micro-sweet, warm in nature, have effect of relaxing muscles and tendons to promote blood circulation, nourishing blood for regulating menstruation, be used for the treatment of numb hand and foot, quadriplegia, rheumatic arthralgia, women have through uncomfortable, dysmenorrhea, amenorrhea.
When taking, will decoct well-done herb liquid and divide and take for two days, the morning, noon and afternoon service once, dosage 180 milliliters/time, taking medicine before meal.To take medicine 34-38 agent, transference cure.This medicine is that have advantages of perfect compatibility, hit pathogenesis with common Chinese herbal medicine for raw material, has fully demonstrated the Therapeutic Principle of nourishing the liver and kidney and blood circulation promoting and blood stasis dispelling.
Detailed description of the invention
Below embodiments of the present invention are described in detail
Central retinochoroiditis is a kind of more common retinopathy, and affected area is mainly limited to macular area.Clinical main manifestations is: blurred vision, seemingly has yarn curtain to hide at the moment, and has vision obscure and metamorphopsia, and their early stage is often with homonymy migraine.First there is macular edema in examination of ocular fundus.Visible circular, the oval or random scatters halation at edema edge, central pit areflexia.Macular area retina swells in vitreous body.Edema area is common has yellow-white or canescence circle to ooze out point, and transudate can be transparent or become muddiness because there is fibrin in liquid.The retinal manifestations of some cases is that simple edema thickens, and the small artery be commonly considered as near macular area shrinks, and makes the telangiectasis of surrounding, causes serosity to infiltrate in neighbouring tissue, thus forms the stagnant phenomenon of surrounding tissue.Any vestige can not be left after this kind of case recovery from illness, vision is unaffected, or seldom be affected.But majority of cases oozes out to show as master clinically.This kind of case, after edema extinction, along with the progressively absorption of exudate, often leaves over tiny pigment, and after recovery from illness, central vision can have impact in various degree.
The present invention is exactly treatment for above-mentioned central retinochoroiditis and a kind of Chinese herbal medicine formula proposed, and adopt herb liquid prepared by this formula, good drug efficacy, instant effect, toxic and side effects is little, can effective therapeutic community's property retinochoroiditis.Below specific embodiment provided by the present invention is described in detail.
Embodiment 1:
12 grams, the one-level Radix Rehmanniae Preparata selecting high-quality clean, 12 grams, Fructus Mori, Fructus Lycii 12 grams, Rhizoma Polygonati 12 grams, Rhizoma Polygonati Odorati 9 grams, Cortex Moutan 9 grams, Fructus Ligustri Lucidi 9 grams, Radix Salviae Miltiorrhizae 12 grams, 6 grams, Flos Carthami, Caulis Spatholobi 9 grams, be ground into graininess for subsequent use respectively; After tying in the above-mentioned granular medicament loading cloth bag crushed, soak in water purification about half an hour, with osmotic drug degree of being organized as, then the clear liquor of soaked medicine and soak medicine is put into boiling machine in the lump, the cold boiled water injecting medicine one-inch carries out first time decoction 25 minutes, after leaching medicinal liquid, re-injects tepor boiled water and carries out second time decoction 20 minutes, merge the herb liquid 1080 milliliters being condensed into 50%, packedly to seal.When taking, will decoct well-done herb liquid and divide and take for two days, the morning, noon and afternoon service once, dosage 180 milliliters/time, taking medicine before meal.To take medicine 34-38 agent, transference cure.
Embodiment 2:
16 grams, the one-level Radix Rehmanniae Preparata selecting high-quality clean, 16 grams, Fructus Mori, Fructus Lycii 16 grams, Rhizoma Polygonati 16 grams, Rhizoma Polygonati Odorati 12 grams, Cortex Moutan 12 grams, Fructus Ligustri Lucidi 12 grams, Radix Salviae Miltiorrhizae 16 grams, 7 grams, Flos Carthami, Caulis Spatholobi 15 grams, be ground into graininess for subsequent use respectively; After tying in the above-mentioned granular medicament loading cloth bag crushed, soak in water purification about half an hour, with osmotic drug degree of being organized as, then the clear liquor of soaked medicine and soak medicine is put into boiling machine in the lump, the cold boiled water injecting medicine one-inch carries out first time decoction 25 minutes, after leaching medicinal liquid, re-injects tepor boiled water and carries out second time decoction 20 minutes, merge the herb liquid 1080 milliliters being condensed into 50%, packedly to seal.When taking, will decoct well-done herb liquid and divide and take for two days, the morning, noon and afternoon service once, dosage 180 milliliters/time, taking medicine before meal.To take medicine 34-36 agent, transference cure.
Embodiment 3:
12 grams, the one-level Radix Rehmanniae Preparata selecting high-quality clean, 12 grams, Fructus Mori, Fructus Lycii 12 grams, Rhizoma Polygonati 12 grams, Rhizoma Polygonati Odorati 9 grams, Cortex Moutan 9 grams, Fructus Ligustri Lucidi 9 grams, Radix Salviae Miltiorrhizae 12 grams, 6 grams, Flos Carthami, Caulis Spatholobi 9 grams, be ground into graininess for subsequent use respectively; After tying in the above-mentioned granular medicament loading cloth bag crushed, soak in water purification about half an hour, with osmotic drug degree of being organized as, then the clear liquor of soaked medicine and soak medicine is put into boiling machine in the lump, the cold boiled water injecting medicine one-inch carries out first time decoction 25 minutes, after leaching medicinal liquid, re-injects tepor boiled water and carries out second time decoction 20 minutes, merge the herb liquid 1080 milliliters being condensed into 50%, packedly to seal.When taking, will decoct well-done herb liquid and divide and take for two days, the morning, noon and afternoon service once, dosage 180 milliliters/time, taking medicine before meal.To take medicine 34-37 agent, transference cure.
Embodiment 4:
16 grams, the one-level Radix Rehmanniae Preparata selecting high-quality clean, 16 grams, Fructus Mori, Fructus Lycii 16 grams, Rhizoma Polygonati 16 grams, Rhizoma Polygonati Odorati 12 grams, Cortex Moutan 12 grams, Fructus Ligustri Lucidi 12 grams, Radix Salviae Miltiorrhizae 16 grams, 7 grams, Flos Carthami, Caulis Spatholobi 15 grams, be ground into graininess for subsequent use respectively; After tying in the above-mentioned granular medicament loading cloth bag crushed, soak in water purification about half an hour, with osmotic drug degree of being organized as, then the clear liquor of soaked medicine and soak medicine is put into boiling machine in the lump, the cold boiled water injecting medicine one-inch carries out first time decoction 25 minutes, after leaching medicinal liquid, re-injects tepor boiled water and carries out second time decoction 20 minutes, merge the herb liquid 1080 milliliters being condensed into 50%, packedly to seal.When taking, will decoct well-done herb liquid and divide and take for two days, the morning, noon and afternoon service once, dosage 180 milliliters/time, taking medicine before meal.To take medicine 34-36 agent, transference cure.
The present invention is through the treatment of the routine patient of logarithm one hundred, and therapeutic effect is remarkable, and toxic and side effects is little, and part allusion quotation shape case is as follows.
1, patient: poplar XX, man, 35 years old, address: Chengdu, Sichuan Province
Illness symptom: visual deterioration, have gray shade more than 3 years at the moment.Patient in recent years vision is significantly gone down, and depending on there being gray circular shadow to obstruct the view during thing at the moment, diminishing depending on thing, can see thing during stravismus, feelings will is not relaxed, and sleeps bad, bitter taste in the mouth and dry throat, yellow urine.Check: conjunctiva of right eye severe is congested, in extremely happy areflexia, vision: left eye 0.7, right eye no light perception.Optical fundus: macula area oozes out edema, the visible circle in edema edge, oval reflection halation, in edema area, visible yellow-white point-like is oozed out.Red tongue with yellow fur, stringy pulse.
Treatment: throw top and control it, every day potion, the morning, noon and afternoon service once, and further consultation after 32 doses of taking medicine, vision brings up to 0.9, and matter basic absorption is oozed out on optical fundus, and metamorphopsia disappears substantially, and advise it to consolidate into medicine 5 doses, vision brings up to 1.0, and all diseases are all removed, and fully recover again.Follow up a case by regular visits to 1 year, have no recurrence.
2, patient: grandson XX, man, 40 years old, address: Jintang County, Sichuan Province
Illness symptom: patient's left eye suffers from central retinochoroiditis, after injection streptomycin first quarter moon, vision brings up to 0.5 by 0.3, and after the nourishing the liver and kidney medicine a few days for oral administration, vision brings up to 0.7, but has shadow at the moment, metamorphopsia.Look into; Macula area, without edema, has point-like yellow to ooze out matter around, red tongue no fur, thready pulse, and card belongs to the hepatic and renal YIN deficiency, and the venation stasis of blood is stagnant.
Treatment: throw top and control it, every day potion, the morning, noon and afternoon service once, further consultation after 35 doses of taking medicine, and vision brings up to 1.0, and matter basic absorption is oozed out on optical fundus, and metamorphopsia disappears, and advise it to consolidate into medicine 3 doses, disease obtains recovery from illness again.Follow up a case by regular visits to 3 year, have no recurrence.
3, patient: woods XX, man, 31 years old, address: Sichuan Province's Deyang City
Illness symptom: main suit: over the past two years visual deterioration, have gray shade more than 1 year at the moment.Recent months visual deterioration is obvious, depending on there being gray circular shadow to obstruct the view during thing at the moment, diminishing depending on thing, can see thing during stravismus, but feelings will is not relaxed, poor sleep, bitter taste in the mouth and dry throat, yellowish or reddish urine.Check: conjunctiva of left eye severe is congested, in extremely happy areflexia, vision: right eye 0.6, left eye no light perception; Optical fundus: macula area oozes out edema, the visible circle in edema edge, oval reflection halation, in edema area, visible yellow-white point-like is oozed out.
Treatment: throw top and control it, every day potion, the morning, noon and afternoon service once, further consultation after 30 doses of taking medicine, and vision brings up to 0.8, and optical fundus is oozed out matter and absorbed, and metamorphopsia disappears substantially, and advise it to enter medicine 7 doses again, vision brings up to 1.0, disease except and heal.Follow up a case by regular visits to 4 years, have no rebound phenomenon.
4, patient: leaf XX, female, 29 years old, address: Sichuan Province's Nanchong City
Illness symptom: left eye suffers from central retinochoroiditis, after once injecting streptomycin and other medicines more than 20 sky, vision brings up to 0.6 by 0.3, but has shadow at the moment, metamorphopsia.Look into; Macula area, without edema, has point-like yellow to ooze out matter around, red tongue no fur, thready pulse, and card belongs to the hepatic and renal YIN deficiency, and the venation stasis of blood is stagnant.
Treatment: throw top and control it, every day potion, the morning, noon and afternoon service once, further consultation after 34 doses of taking medicine, and vision brings up to 1.0, and matter basic absorption is oozed out on optical fundus, and metamorphopsia disappears, and advises it to consolidate into medicine 4 doses again, all diseases all except and heal.Follow up a case by regular visits to 2 years, have no recurrence.
Claims (3)
1. a medicine for therapeutic community's property retinochoroiditis, is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Rehmanniae Preparata 1-3 part;
Fructus Mori 1-3 part;
Fructus Lycii 1-3 part;
Rhizoma Polygonati 1-3 part;
Rhizoma Polygonati Odorati 1-3 part;
Cortex Moutan 1-3 part;
Fructus Ligustri Lucidi 1-3 part;
Radix Salviae Miltiorrhizae 1-3 part;
Flos Carthami 1-3 part;
Caulis Spatholobi 1-3 part.
2. the medicine of therapeutic community's property retinochoroiditis according to claim 1, is characterized in that, each component of described medicine and mass parts thereof are than as follows:
1 part, Radix Rehmanniae Preparata;
1 part, Fructus Mori;
Fructus Lycii 1 part;
Rhizoma Polygonati 1 part;
Rhizoma Polygonati Odorati 1-part;
Cortex Moutan 1 part;
Fructus Ligustri Lucidi 1 part;
Radix Salviae Miltiorrhizae 1 part;
1 part, Flos Carthami;
Caulis Spatholobi 1 part.
3. the medicine of the therapeutic community's property retinochoroiditis described in claim 1 or 2 and a preparation method, is characterized in that, described method comprises the steps:
A, according to mass parts than selecting the clean one-level Radix Rehmanniae Preparata of high-quality, Fructus Mori, Fructus Lycii, Rhizoma Polygonati, Rhizoma Polygonati Odorati, Cortex Moutan, Fructus Ligustri Lucidi, Radix Salviae Miltiorrhizae, Flos Carthami, Caulis Spatholobi, be ground into graininess respectively for subsequent use;
B, the above-mentioned granular medicament that crushes to be loaded in cloth bag after tying, soak in water purification about half an hour, with osmotic drug degree of being organized as, then the clear liquor of soaked medicine and soak medicine is put into boiling machine in the lump, the cold boiled water injecting medicine one-inch carries out first time decoction 25 minutes, after leaching medicinal liquid, re-injects tepor boiled water and carries out second time decoction 20 minutes, merge the herb liquid 1080 milliliters being condensed into 50%, packedly to seal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410739266.8A CN104491403A (en) | 2014-12-08 | 2014-12-08 | Medicine for treating central retinochoroiditis and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410739266.8A CN104491403A (en) | 2014-12-08 | 2014-12-08 | Medicine for treating central retinochoroiditis and preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491403A true CN104491403A (en) | 2015-04-08 |
Family
ID=52932917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410739266.8A Pending CN104491403A (en) | 2014-12-08 | 2014-12-08 | Medicine for treating central retinochoroiditis and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491403A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112426462A (en) * | 2021-01-05 | 2021-03-02 | 河南省科学院 | Hydrogel eye patch for adjuvant therapy of central serous chorioretinopathy and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101700317A (en) * | 2009-11-16 | 2010-05-05 | 武汉代代木生物科技有限公司 | Preparation capable of improving fundus and retina microcirculation lesion and restoring ocular and retina microcirculation lesion and damage and method for preparing same |
-
2014
- 2014-12-08 CN CN201410739266.8A patent/CN104491403A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101700317A (en) * | 2009-11-16 | 2010-05-05 | 武汉代代木生物科技有限公司 | Preparation capable of improving fundus and retina microcirculation lesion and restoring ocular and retina microcirculation lesion and damage and method for preparing same |
Non-Patent Citations (3)
| Title |
|---|
| 唐犀麟: "桑椹地黄汤治疗中央性视网膜脉络膜炎临床观察", 《陕西中医函授》 * |
| 无: "验方集锦", 《家庭医生 快乐养生》 * |
| 李文亮 齐强等编: "《千家妙方 下册》", 28 February 1985, 解放军出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112426462A (en) * | 2021-01-05 | 2021-03-02 | 河南省科学院 | Hydrogel eye patch for adjuvant therapy of central serous chorioretinopathy and preparation method thereof |
| CN112426462B (en) * | 2021-01-05 | 2022-08-30 | 河南省科学院 | Hydrogel eye patch for adjuvant therapy of central serous chorioretinopathy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103740558A (en) | Dendrobium nobile wine and preparation method thereof | |
| CN103432390A (en) | Medicament for treating coronary heart disease and preparation method thereof | |
| CN103977217A (en) | Medicinal composition for treating renal carcinoma | |
| CN104474298A (en) | Traditional Chinese medicine for treating vitiligo | |
| CN104173776A (en) | Pharmaceutical preparation for treating cervicogenic headache and preparation method of pharmaceutical preparation | |
| CN103330854A (en) | Traditional Chinese medicine composition for treating nasal hemorrhage | |
| CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
| CN104491403A (en) | Medicine for treating central retinochoroiditis and preparation method | |
| CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
| CN104547425A (en) | Decoction medicine for treating paralytic strabismus and preparation method pf decoction medicine | |
| CN103961433A (en) | Internal medicine for treating leucoderma and preparation method thereof | |
| CN104173775A (en) | Traditional Chinese medicine composition for treating cervicogenic headache and preparation method of traditional Chinese medicine composition | |
| CN105194288A (en) | Health drink for relieving myopia symptoms and preparation method thereof | |
| CN104524099A (en) | Decoction medicine for treating central retinitis, and preparation method thereof | |
| CN104398847A (en) | Medicinal decoction for treating vitreous opacities and fundus hemorrhage and preparation method | |
| CN104436126A (en) | Orally taken drug for treating Bantis syndrome and preparation method thereof | |
| CN104436122A (en) | Orally-taken medicine for treating climacteric syndrome and preparation method thereof | |
| CN103386083B (en) | A kind of pharmaceutical composition for the treatment of type ii diabetes | |
| CN105125938A (en) | Decoction medicine capable of effectively treating alopecia areata and preparation method thereof | |
| CN104324175A (en) | Internal medicine for treating vocal cord polyp and preparation method thereof | |
| CN104352767A (en) | Traditional Chinese medicine for treating cervicogenic headache | |
| CN104758851A (en) | Traditional Chinese medicine composition for treating stroke sequela | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN104288645A (en) | Traditional Chinese medicine for treating senile cataract | |
| CN104107355A (en) | Ointment for invigorating splenic yang and dispelling fire |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150408 |